Peptides are short chains of amino acids — the same building blocks that make up proteins. The key difference is length: proteins typically contain hundreds or thousands of amino acids, while peptides are generally defined as chains of fewer than 50. This smaller size has profound implications for how they behave in the body.
Because of their compact structure, peptides can cross biological barriers more easily than proteins, bind to specific receptors with high precision, and be synthesized in a laboratory with relative consistency. These properties have made them increasingly attractive to researchers studying everything from wound healing to cognitive enhancement.
How Peptides Work
Peptides function primarily as biological messengers. Many naturally occurring peptides in the human body — such as insulin, oxytocin, and growth hormone-releasing hormone — act as signals that trigger specific physiological responses. Synthetic peptides are designed to mimic or modulate these natural signaling pathways.
The specificity of peptide action is one of their most important properties. Unlike broad-spectrum supplements, a well-characterized peptide typically targets a defined receptor or pathway. BPC-157, for example, appears to act on growth hormone receptors and nitric oxide pathways to accelerate tissue repair. Selank modulates GABA-A receptors and BDNF expression to produce anxiolytic effects.
The Research Landscape
It's important to understand where peptide research currently stands. The majority of evidence for research peptides comes from preclinical studies — primarily animal models. Human clinical trials exist for some compounds (particularly the GLP-1 class like semaglutide, and some growth hormone secretagogues), but many widely-discussed peptides have limited human data.
This doesn't mean the preclinical evidence is irrelevant — animal models often predict human responses reasonably well for certain mechanisms. But it does mean that extrapolating from rodent studies to human protocols requires caution.
Why the Interest is Growing
Several factors are driving increased interest in peptides. First, the success of GLP-1 agonists for metabolic health has demonstrated that peptide-based interventions can produce clinically meaningful outcomes. Second, advances in peptide synthesis have made research-grade compounds more accessible. Third, a growing community of biohackers and longevity researchers has created a body of anecdotal evidence that, while not rigorous, has generated hypotheses worth investigating.
The Bottom Line
Peptides represent a genuinely interesting frontier in health optimization. The science is real, the mechanisms are plausible, and for some compounds, the evidence is compelling. But the field also attracts significant hype, and the gap between what's proven and what's claimed is often large. Our goal at PeptidePilot is to help you navigate that gap — matching you to compounds where the evidence is strongest for your specific profile.